CVN45502

CVN45502
Legal status
Legal status	Investigational;
Identifiers
	IUPAC name N-[(1S,2S)-2-Methyl-2-[[5-(trifluoromethyl)pyrazin-2-yl]amino]cyclopentyl]-3-(triazol-2-yl)pyridine-2-carboxamide;
PubChem CID	118308152;
ChemSpider	76767388;
ChEMBL	ChEMBL3932722;
Chemical and physical data
Formula	C19H19F3N8O
Molar mass	432.411 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@@]1(CCC[C@@H]1NC(=O)C2=C(C=CC=N2)N3N=CC=N3)NC4=NC=C(N=C4)C(F)(F)F;
	InChI InChI=1S/C19H19F3N8O/c1-18(29-15-11-24-14(10-25-15)19(20,21)22)6-2-5-13(18)28-17(31)16-12(4-3-7-23-16)30-26-8-9-27-30/h3-4,7-11,13H,2,5-6H2,1H3,(H,25,29)(H,28,31)/t13-,18-/m0/s1; Key:UNZFNWZMBMDMAR-UGSOOPFHSA-N;

CVN45502 is a selective hypocretin (orexin) receptor 1 antagonist. It significantly reduces food intake and body weight in a mouse model of obesity.^[1] Although HCRTR1 variants are significantly correlated with body weight in humans, it is not known if the drug has psychiatric side effects or could be combined with GLP-1 agonists.^[2]

References

^ Schneeberger, Marc; Brice, Nicola L.; Pellegrino, Kyle; Parolari, Luca; Shaked, Jordan T.; Page, Keith J.; Marchildon, François; Barrows, Douglas W.; Carroll, Thomas S.; Topilko, Thomas; Mulligan, Victoria M.; Newman, Robert; Doyle, Kevin; Bürli, Roland; Barker, Daniel F.; Glen, Angela; Ortuño, María José; Nectow, Alexander R.; Renier, Nicolas; Cohen, Paul; Carlton, Mark; Heintz, Nathaniel; Friedman, Jeffrey M. (November 2022). "Pharmacological targeting of glutamatergic neurons within the brainstem for weight reduction". Nature Metabolism. 4 (11): 1495–1513. doi:10.1038/s42255-022-00677-8. ISSN 2522-5812. PMC 9684079. PMID 36411386.
^ Tsang, Anthony; Blouet, Clemence (April 2023). "A pipeline for identification and validation of brain targets for weight loss". Nature Reviews Endocrinology. 19 (4): 190–191. doi:10.1038/s41574-023-00803-w. ISSN 1759-5037. PMID 36697769.

This medical article is a stub. You can help Wikipedia by expanding it.

[1] Schneeberger, Marc; Brice, Nicola L.; Pellegrino, Kyle; Parolari, Luca; Shaked, Jordan T.; Page, Keith J.; Marchildon, François; Barrows, Douglas W.; Carroll, Thomas S.; Topilko, Thomas; Mulligan, Victoria M.; Newman, Robert; Doyle, Kevin; Bürli, Roland; Barker, Daniel F.; Glen, Angela; Ortuño, María José; Nectow, Alexander R.; Renier, Nicolas; Cohen, Paul; Carlton, Mark; Heintz, Nathaniel; Friedman, Jeffrey M. (November 2022). "Pharmacological targeting of glutamatergic neurons within the brainstem for weight reduction". Nature Metabolism. 4 (11): 1495–1513. doi:10.1038/s42255-022-00677-8. ISSN 2522-5812. PMC 9684079. PMID 36411386.

[2] Tsang, Anthony; Blouet, Clemence (April 2023). "A pipeline for identification and validation of brain targets for weight loss". Nature Reviews Endocrinology. 19 (4): 190–191. doi:10.1038/s41574-023-00803-w. ISSN 1759-5037. PMID 36697769.

[1]

[2]